Evidence map›Paper›PMID 27264171›Full record

ArticleCell reports2016

Type I Interferon Induction by Neisseria gonorrhoeae: Dual Requirement of Cyclic GMP-AMP Synthase and Toll-like Receptor 4.

Warrison A Andrade, Sarika Agarwal, Shunyan Mo, Scott A Shaffer, Joseph P Dillard, Tobias Schmidt, Veit Hornung, Katherine A Fitzgerald, Evelyn A Kurt-Jones, Douglas T Golenbock

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Immunomodulatory Role of Interferons in Viral and Bacterial Infections.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Mechanisms of host manipulation byFrontiers in microbiology · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. The multifaceted functions of cGAS.Journal of molecular cell biology · 2022
    Review
  15. Signaling pathways in obesity: mechanisms and therapeutic interventions.Signal transduction and targeted therapy · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Warrison A AndradeDivision of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Sarika AgarwalDivision of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Shunyan MoProteomics and Mass Spectrometry Facility, University of Massachusetts Medical School, Worcester, MA 01605, USA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Scott A ShafferProteomics and Mass Spectrometry Facility, University of Massachusetts Medical School, Worcester, MA 01605, USA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Joseph P DillardDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Tobias SchmidtInstitute of Molecular Medicine, Universitätsklinikum Bonn, Bonn 53127, Germany.
Veit HornungInstitute of Molecular Medicine, Universitätsklinikum Bonn, Bonn 53127, Germany.
Katherine A FitzgeraldDivision of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA; Centre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway.
Evelyn A Kurt-JonesDivision of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Douglas T GolenbockDivision of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA; Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil. Electronic address: douglas.golenbock@umassmed.edu.
University of Massachusetts Chan Medical School · USUniversity Hospital Bonn · DENorwegian University of Science and Technology · NOUniversity of Wisconsin–Madison · US

Funding

The TLR4/MD-2 signaling pathway in gonoccocal diseaseU19AI084048 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RICE, PETER A. · 2009 to 2013
$13.1M
Innate Immune Activation in MalariaR01AI079293 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., GOLENBOCK, DOUGLAS T · 2009 to 2024
$10.9M
Type IV Secretion by Neisseria gonorrhoeaeR01AI047958 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI DILLARD, JOSEPH P · 2002 to 2019
$5.0M
Phagocyte Receptors for Lipid AR37GM054060 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T · 2008 to 2017
$4.4M
Role of the cytosolic DNA sensor cGAS in malariaR21AI124171 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T · 2016 to 2017
$437k
NIAID NIH HHS R01 AI047958NIAID NIH HHS R01 AI079293NIAID NIH HHS R21 AI124171NIAID NIH HHS U19 AI084048NIGMS NIH HHS R37 GM054060
6 · The paper itself

Abstract

The innate immune system is the first line of defense against Neisseria gonorrhoeae (GC). Exposure of cells to GC lipooligosaccharides induces a strong immune response, leading to type I interferon (IFN) production via TLR4/MD-2. In addition to living freely in the extracellular space, GC can invade the cytoplasm to evade detection and elimination. Double-stranded DNA introduced into the cytosol binds and activates the enzyme cyclic-GMP-AMP synthase (cGAS), which produces 2'3'-cGAMP and triggers STING/TBK-1/IRF3 activation, resulting in type I IFN expression. Here, we reveal a cytosolic response to GC DNA that also contributes to type I IFN induction. We demonstrate that complete IFN-β induction by live GC depends on both cGAS and TLR4. Type I IFN is detrimental to the host, and dysregulation of iron homeostasis genes may explain lower bacteria survival in cGAS(-/-) and TLR4(-/-) cells. Collectively, these observations reveal cooperation between TLRs and cGAS in immunity to GC infection.

Indexed as

Bacterial Secretion SystemsCell LineCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNA, BacterialHumansInterferon Type IIronMembrane ProteinsMicrobial ViabilityNeisseria gonorrhoeaeNucleotides, CyclicNucleotidyltransferasesSTING ProteinToll-Like Receptor 4TransfectionBacterial Secretion SystemscGAS protein, humancyclic guanosine monophosphate-adenosine monophosphateCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNA, BacterialInterferon Type IIronMembrane ProteinsNucleotides, CyclicNucleotidyltransferasesSTING1 protein, humanSting1 protein, mouseSTING ProteinToll-Like Receptor 4cGASNeisseria gonorrhoeaeSTINGTLR4type I interferon

Identifiers

PMID27264171
PMCPMC5401638
OpenAlexW2413646558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.